Mizuho Trust & Banking’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-297,085
Closed -$25.1M 194
2016
Q3
$25.1M Buy
297,085
+596
+0.2% +$50.1K 0.07% 288
2016
Q2
$24.1M Buy
296,489
+82,688
+39% +$6.3M 0.07% 288
2016
Q1
$15.3M Buy
213,801
+5,185
+2% +$348K 0.05% 413
2015
Q4
$15M Buy
208,616
+2,626
+1% +$177K 0.05% 406
2015
Q3
$12.7M Buy
205,990
+4
+0% +$280 0.04% 446
2015
Q2
$14.9M Buy
205,986
+7,693
+4% +$568K 0.05% 409
2015
Q1
$15.2M Buy
198,293
+4,312
+2% +$309K 0.05% 410
2014
Q4
$13M Buy
193,981
+14,554
+8% +$918K 0.05% 446
2014
Q3
$10.9M Sell
179,427
-5,878
-3% -$362K 0.04% 462
2014
Q2
$10.9M Sell
185,305
-5,645
-3% -$331K 0.04% 498
2014
Q1
$11.1M Sell
190,950
-22,535
-11% -$1.21M 0.04% 476
2013
Q4
$11.6M Sell
213,485
-1,100
-0.5% -$65.2K 0.04% 451
2013
Q3
$13M Hold
214,585
0.05% 395
2013
Q2
$13M Buy
+214,585
New +$12.8M 0.05% 395

Other funds holding DGX

Mizuho Trust & Banking's DGX Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 297,085 shares — an estimated $25.1M sold.

Mizuho Trust & Banking first reported a position in DGX in Q2 2013 and held it in 14 quarters. The position peaked at $25.1M in Q3 2016. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 297,085 Quest Diagnostics shares in Q4 2016, an estimated $25.1M.
  • Mizuho Trust & Banking first reported a position in Quest Diagnostics in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Quest Diagnostics position peaked at $25.1M in Q3 2016.
  • 597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.